Bidur is a Research Scientist in the Cardiovascular Disease Initiative Program of the Broad Institute. He received his Ph.D. in Biomedical Science from Jeonbuk National University, South Korea under the mentorship of Han Jung Chae, Ph.D., in 2014. After graduation, he joined the laboratory of Jeffrey Robbins, Ph.D. in the Division of Molecular Cardiovascular Biology, Cincinnati Children’s Hospital, for his postdoctoral training. In the lab, he was involved in understanding the role of myofibroblast specific TGF-beta signaling in the progression of cardiac fibrosis in mouse models of human heart failure. Upon joining Ellinor Lab in January 2020, Bidur is focused on identifying and characterizing novel cardiovascular therapeutic targets in the partnership program between Broad Institute and Bayer Healthcare.